Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that was histopathologically characterized in the brain by the presence of extracellular senile plaques made of amyloid β peptides and intracellular neurofibrillary tangles composed of hyperphosphorylated Tau protein. Over the years...
Main Authors: | Miren Ettcheto, Oriol Busquets, Antoni Camins |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2019;volume=14;issue=10;spage=1721;epage=1725;aulast=Ettcheto |
Similar Items
-
Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
by: Saghar Rabiei Poor, et al.
Published: (2021-09-01) -
Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
by: Tiwari S, et al.
Published: (2019-07-01) -
Alzheimer’s Disease: Background, Current and Future Treatments
by: Evelyn Chou
Published: (2014-06-01) -
Alzheimer’s Disease: Current and Future Treatments. A Review
by: Evelyn Chou
Published: (2014-05-01) -
Can Neurostimulation Prevent the Risk of Alzheimer’s Disease in Elderly Individuals with Schizophrenia?
by: Adonis eSfera, et al.
Published: (2013-09-01)